We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Marker

News List

Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas firstwordpharma
August 20, 2021
Marker today announced that the Company received notice of a Product Development Research award totaling approximately $13.1 million from the CPRIT to support the Company's Phase 2 clinical trial of its lead MultiTAA-specific T cell product MT-401.
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility americanpharmaceuticalreview
August 02, 2021
Marker Therapeutics, Inc. announced that the Company's new cGMP manufacturing facility in Houston, TX, located near the George Bush Intercontinental Airport, is fully operational.
Marker Therapeutics Appoints Regulatory Affairs VP contractpharma
August 19, 2019
Dr. Agopyan brings more than 15 years of industry knowledge in regulatory affairs and clinical development.